Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Alp, Keziban Merve (1) Birchmeier, Walter Prof. Dr. (7) Blankenstein, Thomas Prof. Dr. (3) Blüthgen, Nils (1) Cakmak-Görür, Nese Dr. (1) Dahlmann, Mathias Dr. (29) Daniel, Peter Prof. Dr. (3) Dörr, Jan Rafael (1) Fritsche, Raphaela Dr. (2) Haas, Simon Dr. rer. nat. (4) Hartl, Kimberly (1) Herse, Florian PD Dr. (1) Holz, Maximilian (1) Höpken, Uta Elisabeth PD Dr. (1) Horne, Arik (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (1) Janz, Martin Dr. (6) Kempa, Stefan Dr. (1) Kobelt, Dennis Dr. (51) Koch, Gudrun (1) Leutz, Achim Prof. Dr. (2) Malchin, Victoria (1) Mathas, Stephan Dr. (4) Mertins, Philipp Dr. (6) Na, Il-Kang Dr. (4) Nazare, Marc (1) Nguyen, Tam Hoai Dr. (1) Nimptsch, Katharina Dr. (1) Özerdem, Ceren (1) Pischon, Tobias Prof. Dr. (1) Popp, Oliver Dr. (4) Rathjen, Fritz Prof. Dr. (1) Rehm, Armin Dr. (1) Rhein, Simone Dr. (2) Röefzaad, Claudia (1) Sapozhnikova, Valeriia (1) Schlag, Peter M. Prof. Dr. (378) Schmitt, Clemens Prof. Dr. (4) Schöpe, Paul Curtis (2) Schroeder, Leif Dr. (1) Simon, Mareike Dr. (1) Smith, Janice (17) Solé Boldo, Llorenc Dr. rer. nat. (1) Specker, Edgar Dr. (2) Sperling, Silke Prof. Dr. (1) Sporbert, Anje Dr. (1) Stein, Ulrike Prof. Dr. (189) Strzelecka, Paulina Maria (1) Torke, Sebastian Dr. (4) Uckert, Wolfgang Prof. Dr. (1) Veltsista, Paraskevi Danai (2) von Kries, Jens Peter Dr. (2) Walther, Wolfgang Prof. Dr. (147) Wenzel, Katrin Dr. (1) Willimsky, Gerald Dr. (2) Willnow, Thomas Prof. Dr. (1) Wolf, Jana Prof. Dr. (1) Yousefian, Schayan (2) Ziehm, Matthias Dr. (1) Zimmermann, Karin Dr. (1) (-) Beule, Dieter Dr. (4) (-) Pezzutto, Antonio Prof. Dr. (11) 2005 (1) 2012 (2) 2013 (1) 2015 (1) 2016 (1) 2021 (2) 2022 (3) 2023 (2) 2024 (1) Advanced Light Microscopy (1) AG Müller/Dechend (ECRC) (1) Animal Phenotyping (3) Biology of Malignant Lymphomas (2) Biomedical Image Analysis (1) Cellular Neurosciences (4) Chemical Biology (1) Computational methodologies and omic analytics (1) Computational Regulatory Genomics (2) Developmental Neurobiology (1) Epigenetic Regulation and Chromatin Architecture (1) Experimental Ultrahigh-Field MR (1) Flow Cytometry (1) Genetics and Genomics of Cardiovascular Diseases (2) Genetics of Congenital Heart Disease (4) Genomics (5) Host-microbiome factors in cardiovascular disease (1) Hypertension-caused End-Organ Damage (1) Hypertension-Mediated End-Organ Damage (1) Immune Regulation and Cancer (1) Integrative Vascular Biology (1) Magnetic Resonance (1) (-) Mechanism-based Cancer Therapies (11) Microenvironmental Regulation in Autoimmunity and Cancer (5) Mobile DNA (2) Molecular Cardiovascular Research (1) Molecular Genetics of Chronic Inflammation and Allergic Disease (1) Molecular Immunology and Gene Therapy (22) Organoids (1) Out-patient Clinic for Neuroimmunology (1) Proteome Dynamics (2) Proteomics (6) Proteomics and Metabolomics (1) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (2) Psychoneuroimmunology (4) RNA Biology and Posttranscriptional Regulation (7) Screening Unit (1) Structural Biology of Membrane-Associated Processes (2) Systems Biology of Gene Regulatory Elements (1) Systems Hematology, Stem Cells & Precision Medicine (2) Translational Bioinformatics (100) Translational Cardiology and Functional Genomics (2) (-) Translational Oncology of Solid Tumors (4) Translational Organ Models (2) Translational Tumorimmunology (2) 14 Results: Active Filter: Beule, Dieter Dr.Pezzutto, Antonio Prof. Dr.Mechanism-based Cancer TherapiesTranslational Oncology of Solid Tumors Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto August, 2024 / Nat Cancer The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities E. Ramberger V. Sapozhnikova Y.L.D. Ng A. Dolnik M. Ziehm O. Popp E. Sträng M. Kull F. Grünschläger J. Krüger M. Benary S. Müller X. Gao A. Murgai M. Haji A. Schmidt R. Lutz A. Nogai J. Braune D. Laue C. Langer C. Khandanpour F. Bassermann H. Döhner M. Engelhardt C. Straka M. Hundemer D. Beule S. Haas U. Keller H. Einsele L. Bullinger S. Knop P. Mertins J. Krönke July 30, 2021 / J Immunother Cancer High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies Ö. Çınar B. Brzezicha C. Grunert P.M. Kloetzel C. Beier C.A. Peuker U. Keller A. Pezzutto A. Busse 2023 / Front Oncol Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma D.T. Rieke S. Schröder P. Schafhausen E. Blanc E. Zuljan B. von der Emde D. Beule U. Keller U. Keilholz K. Klinghammer November, 2023 / JAMA Netw Open Leveraging large language models for decision support in personalized oncology M. Benary X.D. Wang M. Schmidt D. Soll G. Hilfenhaus M. Nassir C. Sigler M. Knödler U. Keller D. Beule U. Keilholz U. Leser D.T. Rieke May 12, 2021 / Cancers Spontaneous non-sustained ventricular tachycardia and premature ventricular contractions and their prognostic relevance in patients with cancer in routine care A. Albrecht J. Porthun J. Eucker A.J.S. Coats S. von Haehling A. Pezzutto M. Karakas H. Riess U. Keller U. Landmesser W. Haverkamp S.D. Anker M.S. Anker April, 2022 / Ann Hematol 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years K. Rieger R. De Filippi O. Lindén A. Viardot G. Hess K. Lerch P. Neumeister A. Stroux C.A. Peuker A. Pezzutto A. Pinto U. Keller C.W. Scholz January 20, 2013 / J Clin Oncol (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial C.W. Scholz A. Pinto W. Linkesch O. Lindén A. Viardot U. Keller G. Hess S. Lastoria K. Lerch F. Frigeri M. Arcamone A. Stroux B. Frericks C. Pott A. Pezzutto December 01, 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann June, 2015 / Ann Hematol Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis K. Lerch A.H. Meyer A. Stroux C. Hirt U. Keller A. Viardot R. Marks S. Schreiber A. Pezzutto C.W. Scholz Pagination Current page 1 Page 2 Next page Next › Last page Last »
January 01, 2005 / J Immunol Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein O. Schmetzer G. Moldenhauer R. Riesenberg J.R. Pires P.M. Schlag A. Pezzutto
August, 2024 / Nat Cancer The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities E. Ramberger V. Sapozhnikova Y.L.D. Ng A. Dolnik M. Ziehm O. Popp E. Sträng M. Kull F. Grünschläger J. Krüger M. Benary S. Müller X. Gao A. Murgai M. Haji A. Schmidt R. Lutz A. Nogai J. Braune D. Laue C. Langer C. Khandanpour F. Bassermann H. Döhner M. Engelhardt C. Straka M. Hundemer D. Beule S. Haas U. Keller H. Einsele L. Bullinger S. Knop P. Mertins J. Krönke
July 30, 2021 / J Immunother Cancer High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies Ö. Çınar B. Brzezicha C. Grunert P.M. Kloetzel C. Beier C.A. Peuker U. Keller A. Pezzutto A. Busse
2023 / Front Oncol Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma D.T. Rieke S. Schröder P. Schafhausen E. Blanc E. Zuljan B. von der Emde D. Beule U. Keller U. Keilholz K. Klinghammer
November, 2023 / JAMA Netw Open Leveraging large language models for decision support in personalized oncology M. Benary X.D. Wang M. Schmidt D. Soll G. Hilfenhaus M. Nassir C. Sigler M. Knödler U. Keller D. Beule U. Keilholz U. Leser D.T. Rieke
May 12, 2021 / Cancers Spontaneous non-sustained ventricular tachycardia and premature ventricular contractions and their prognostic relevance in patients with cancer in routine care A. Albrecht J. Porthun J. Eucker A.J.S. Coats S. von Haehling A. Pezzutto M. Karakas H. Riess U. Keller U. Landmesser W. Haverkamp S.D. Anker M.S. Anker
April, 2022 / Ann Hematol 90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years K. Rieger R. De Filippi O. Lindén A. Viardot G. Hess K. Lerch P. Neumeister A. Stroux C.A. Peuker A. Pezzutto A. Pinto U. Keller C.W. Scholz
January 20, 2013 / J Clin Oncol (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial C.W. Scholz A. Pinto W. Linkesch O. Lindén A. Viardot U. Keller G. Hess S. Lastoria K. Lerch F. Frigeri M. Arcamone A. Stroux B. Frericks C. Pott A. Pezzutto
December 01, 2012 / OncoImmunology HER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model: gene gun is superior to jet injector in inducing CTL responses and protective immunity T. Nguyen-Hoai D. Kobelt O. Hohn M.D. Vu P.M. Schlag B. Doerken S. Norley M. Lipp W. Walther A. Pezzutto J. Westermann
June, 2015 / Ann Hematol Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis K. Lerch A.H. Meyer A. Stroux C. Hirt U. Keller A. Viardot R. Marks S. Schreiber A. Pezzutto C.W. Scholz